Synapse - Ferrata Storti Foundation

Results (354)

Analysis of the genomic landscape of multiple myeloma highlights novel candidate prognostic markers and disease subgroups

Meeting Abstract

Bolli, N.; Biancon, G.; Moarii, M.; Gimondi, S.; Li, Y.; De Philippis, C.; Maura, F.; Sathiaseelan, V.; Yu-Tzu, T.; Mudie, L.; more...
Haematologica (2017)

Fulltext@MSK | Save

WT1 heteroclitic epitope immunization following autologous stem cell transplantation in patients with high-risk multiple myeloma (MM)

Meeting Abstract

Koehne, G.; Devlin, S.; Chung, D.; Landau, H.; Korde, N.; Mailankody, S.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Giralt, S.; more...
Haematologica (2017)

Fulltext@MSK | Save

Durable long-term survival of adult patients with B-ALL after CD19 CAR (19-28z) T cell therapy

Meeting Abstract

Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Purdon, T.; Brentjens, R.; Sadelain, M.
Haematologica (2017)

Fulltext@MSK | Save

Variant FLT3 mutations can be eradicated by cytarabine/anthracycline/crenolanib induction in adult patients with newly diagnosed FLT3 (ITK/TKD) mutant AML

Meeting Abstract

Wang, E.; Stone, R.; Collins, R.; Agrawal, T.; Urity, V.; Tallman, M.
Haematologica (2017)

Fulltext@MSK | Save

Patients with acute myeloid leukemia who have mutations in IDH1 or IDH2 respond well to induction chemotherapy with "7+3" despite the presence of complex karyotype or FLT3-ITD

Meeting Abstract

Gupta, D. M.; Devlin, D. S.; Tallman, D. M.; Stein, D. E.
Haematologica (2017)

Fulltext@MSK | Save

Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL)

Meeting Abstract

Davids, M. S.; Roberts, A. W.; Seymour, J. F.; Wierda, W. G.; Puvvada, S. D.; Gressick, L.; Alter, D.; Zhou, L.; Kim, S. Y.; Verdugo, M.; more...
Haematologica (2017)

Fulltext@MSK | Save

Phase 3 ALCANZA study of brentuximab vedotin (BV) or physician's choice (PC) of methotrexate (MTX) or bexarotene (Bex) in CD30-positive cutaneous T-cell lymphoma (CTCL): Number needed to treat analysis

Meeting Abstract

Zagadailov, E.; Prince, H. M.; Whittaker, S.; Horwitz, S.; Duvic, M.; Kim, Y.; Dummer, R.; Scarisbrick, J.; Quaglino, P.; Zinzani, P. L.; more...
Haematologica (2017)

Fulltext@MSK | Save

Timing of defibrotide initiation post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after primary chemotherapy: Exploratory analysis of an expanded-access protocol

Meeting Abstract

Kernan, N.; Richardson, P.; Triplett, B.; Grupp, S.; Antin, J.; Liang, W.; Hume, R.; Tappe, W.; Soiffer, R.
Haematologica (2017)

Fulltext@MSK | Save

Multiple myeloma and comorbidity: A population-based study

Meeting Abstract

Sverrisdottir, I. S.; Rögnvaldsson, S.; Lund, S. H.; Turesson, I.; Hultcrantz, M.; Björkholm, M.; Landgren, O.; Kristinsson, S. Y.
Haematologica (2017)

Fulltext@MSK | Save

Defibrotide efficacy and safety in patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) diagnosed after day 21: Analysis of final data from an expanded-access program

Meeting Abstract

Richardson, P.; Smith, A.; Triplett, B.; Kernan, N.; Grupp, S.; Antin, J.; Lehmann, L.; Giralt, S.; Ryan, R.; Hume, R.; more...
Haematologica (2017)

Fulltext@MSK | Save

Ferrata Storti Foundation

People

Groups

Results (354)

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Ferrata Storti Foundation – authorized name for: